Blog
From Self-Reported to Sensor-Driven: Key Takeaways from SCOPE 2025
What’s next for clinical trials? See our top takeaways from SCOPE 2025, including how sensor-driven data and patient engagement are changing the game.
17/02/2025
What’s next for clinical trials? See our top takeaways from SCOPE 2025, including how sensor-driven data and patient engagement are changing the game.
Digital endpoints enable continuous, objective, and remote patient monitoring through sensors and wearables, improving data quality and the patient experience in clinical trials.
Learn how EDC systems play a vital role in GDPR compliance for clinical trials, supporting data security, audit trails, and participant consent management.
Learn how to solve retention, compliance, and data quality challenges in clinical trials, drawing insights from our eBook.
Adapted from a Clinical Trials Arena article, this piece explores how gamification enhances clinical trial engagement, with insights from Replior CEO Christer Nilsson.
Digital endpoints enable continuous, objective, and remote patient monitoring through sensors and wearables, improving data quality and the patient experience in clinical trials.
Download our expert guide to selecting the right ePRO tool for clinical trials. Enhance patient engagement, ensure data accuracy, and make informed decisions with our practical checklist.
Digital endpoints enable continuous, objective, and remote patient monitoring through sensors and wearables, improving data quality and the patient experience in clinical trials.
How Replior’s integrated UV monitoring improves patient engagement in the Almirall AKtive trial, a phase IV study.
The SCAPIS study collected and analyzed 30+ million data points from 30,154 participants with Replior.
Copyright 2025 © All rights Reserved. Replior AB
